Looking for a buyer.
An opportunity exists to acquire our client, the creator of a line of green, alcohol-free, and patented instant hand sanitizers. The global market for instant hand sanitizers was valued at $14.2 billion in 2022, with projections to reach $25.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2023 to###-###-#### Despite this favorable market our client is seeking to sell the business due to personal considerations and the seller’s involvement in an exciting new startup venture.
Our client was a pioneer in the alcohol-free hand sanitizer space, introducing their sanitizer products as a gentle yet effective alternative, particularly ideal for new moms and individuals with dry or sensitive skin. Its alcohol-free formulation makes it a skin-friendly option, addressing a growing need for products that provide protection without the harsh effects of alcohol.
The company has significant industry experience with products once sold in over 5,000 retail outlets and has garnered multiple prestigious awards. The demand for alcohol-free sanitizers is the fastest-growing segment of the personal care market, presenting a substantial opportunity for further expansion. Pratt & Whitney, one of America’s largest defense contractors, mandates the use of our client’s sanitizer products in their facilities for its safety around sensitive and expensive electronics, highlighting the product’s unique appeal in both high-tech environments and the broader consumer market. Our client began their business as a small venture in the kitchen of the seller, a working mom who sought a safe, effective hand sanitizer alternative for her family. The result was the seller’s sanitizer products, the first alcohol-free hand sanitizer, now patented and sold across various markets. Over the years, the company grew significantly and earned multiple awards for its innovative products, staying true to its mission of providing safer, eco-friendly personal care solutions.
Our client believes the business can be better leveraged and scaled by a larger consumer-products company. Hand sanitizers remain in high demand due to their antiseptic qualities and convenience, serving as an effective substitute for soap and water to help prevent infectious diseases such as norovirus, COVID-19, influenza, meningitis, MRSA, and pertussis.
Primarily due to the impact of COVID-19, the seller could not keep the product going, and with sales effectively back to the starting point, the seller has decided to offer the business including all patents, customer base, and history for sale.
NDA is required to secure comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
Facilities: N/A
Competition: Per CIM
Growth & Expansion: Per CIM
Financing: Negotiable if the price and deal structure are right
Support & Training: Per CIM
Reason for Selling: Other Interests
listing type
exclusive representation
exclusive representation
industry
Manufacturing
Manufacturing
location
New York, NY, USA
New York, NY, USA
revenue
$10,495
$10,495
ebitda
$2,871
$2,871
To download teaser or contact poster, please sign in.
29 views
0 comments
Sign in to see all replies.
Create an account.